Unisound AI Technology Co., Ltd. 雲知聲智能科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） 股份代號：9678 2025 中期報告 2025 Interim Report Stock Code: 9678 Unisound AI Technology Co., Ltd. 雲知聲智能科技股份有限公司 u nd AI Te c h n olo gy U nis o C o., Lt d. 雲知聲 智 能 科 技 股 份 有 限 公 司 2025 Interim Report 中期報告 (A joint stock company incorporated in the People's Republic of China with limited liability) 目錄 | 釋義 | 2 | | | --- | --- | --- | | 公司資料 | 5 | | | 財務摘要 | 7 | | | 8 | | 管理層討論與分析 | | 24 | | 企業管治及其他資料 | | 獨立核數師報告 | 33 | | | 35 | | 中期簡明合併全面收益表 | | 37 ...

9月26日，第十五届中国河南国际投资贸易洽谈会在郑州开幕。作为河南省规模最大、规格最高、最具 影响力的国际经贸盛会，河南投洽会已成功举办14届，成为河南对外开放的"金字招牌"。云知声智能科 技股份有限公司（股票代码：09678.HK）CEO黄伟博士作为从河南走出的AI领域商业精英与豫商代表 受邀出席，并以《产业智能体——中国AI产业破局之路》为题发表精彩主旨演讲。 "政策规划正以超越技术本身发展的速度，为AI产业指明方向。"黄伟博士特别强调。8月26日国务院发 布的"人工智能+"行动纲领，为我国AI产业制定了明确的战略执行路径。而河南省的表现尤为亮眼—— 早在5月26日就先于国务院发布了本年度"AI+"行动计划，并在国家政策发布后仅两周就推出切合本省产 业优势的实施细则，展现出"快速精准"的响应能力。 专业级大模型与产业智能体构建破局之道 随着政策链的完善，技术链和产业链也迎来质变前夜。黄伟博士认为，相较于普通垂类大模型，专业级 大模型与产业智能体才是真正的破局之道。"如果专业级大模型是发电厂，那产业智能体就是各种耗电 大户。"这一转变将推动新质生产力从线性增长迈向指数级增长。 他提出，专业级大模型需要满足三 ...

Core Viewpoint - Yunzhisheng has been officially included in the Hong Kong Stock Connect list, reflecting strong market recognition and opening new opportunities for liquidity and financing, following its successful listing as the "first AGI stock" in Hong Kong [1][12]. Financial Performance - In the first half of 2025, Yunzhisheng reported a revenue of 405 million RMB, achieving a year-on-year growth of 20.2%, demonstrating resilience amid increasing competition in the AI industry [3]. - The revenue from large model-related businesses surged by 457% year-on-year, nearing 100 million RMB, showcasing the company's ability to convert technology into commercial value [5]. - The AI chip sales reached 16.5 million units in the first half of the year, with cumulative shipments exceeding 100 million units, supporting daily life applications [5]. - The insurance business revenue skyrocketed by 1386.8% year-on-year, indicating a significant breakthrough and new growth trajectory [5]. - In the high-value "AI + healthcare" sector, the average revenue per customer increased by 116.2% year-on-year, highlighting market recognition of its healthcare AI solutions [5]. Technological Advancements - Yunzhisheng has intensified its investment in technology research and development, focusing on its self-developed Atlas intelligent computing platform to strengthen technological barriers [6]. - The company successfully compressed model parameters to below 0.5 billion through advanced model distillation technology, developing high-performance, low-latency edge models that have been successfully delivered in various vehicle models [6]. - The company has expanded its language model capabilities to cover multiple languages and dialects, enhancing speech recognition and semantic understanding in multilingual environments [8]. Market Expansion and Policy Support - Yunzhisheng has accelerated its domestic and international collaboration, signing memorandums with the government of Vanuatu and establishing a project in Southeast Asia [10]. - The company has formed strategic partnerships with health authorities and insurance companies in China, deepening its penetration in core sectors [10]. - Recent government policies promoting the integration of AI with various industries align with Yunzhisheng's strategic direction, providing a favorable environment for its growth [12].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表 任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責任。 UNISOUND AI TECHNOLOGY CO., LTD. 雲知聲智能科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） 承董事會命 （股份代號：9678） 公 告 暫停辦理股份過戶登記手續 雲知聲智能科技股份有限公司（「本公司」）董事會（「董事會」）謹此宣佈，本公司擬於2025 年10月17日（星期五）舉行2025年第二次臨時股東大會（「臨時股東大會」）。 為確定有權出席臨時股東大會並於會上投票的本公司H股股東名單，本公司將自2025年 9月27日（星期六）起至2025年10月17日（星期五）止期間（包括首尾兩日）暫停辦理H股股份 過戶登記，該期間不辦理H股股份過戶登記手續。於2025年10月17日（星期五）名列本公 司股東名冊的H股股東將有權出席臨時股東大會並可於會上投票。 載有於臨時股東大會上提呈的決議案詳情的通函連同臨時股東大會的通告將分別在香 港聯合交易所有限公司披露易網站( w ...

Core Viewpoint - The Hong Kong stock market experienced a decline across all major indices, while AI solution provider Yunzhisheng (9678.HK) saw a significant increase of 26.55% to HKD 591 due to its announcement regarding the conversion of non-listed shares to H-shares [1] Company Summary - Yunzhisheng announced that it has submitted an application to the China Securities Regulatory Commission (CSRC) to convert 24,488,277 domestic non-listed shares and 4,570,649 non-listed foreign shares into H-shares [1] - The conversion will allow these shares to be listed and traded on the main board of the Hong Kong Stock Exchange, pending approval from relevant regulatory bodies including the CSRC and the Stock Exchange [1] - As of the announcement date, the company has not yet completed the filing with the CSRC regarding this application and will provide further updates on the progress and details at an appropriate time [1]

Core Insights - Cloud Wisdom (09678.HK) has been officially included in the Hang Seng Composite Index and the Hong Kong Stock Connect, reflecting strong market recognition of its capabilities in medical AI applications [1][3] - The inclusion was anticipated by Huatai Securities, which highlighted that Cloud Wisdom met the criteria for inclusion based on market capitalization (over HKD 40 billion), liquidity, and listing duration [3] - The company has established a three-layer technological framework that supports its growth, consisting of a robust AI infrastructure, a large medical model, and application solutions focused on healthcare and daily life [3][4] Company Performance - The medical AI solution has demonstrated significant efficiency improvements, with an 80% increase in medical record entry efficiency and a 15% reduction in doctor consultation time [4] - The adoption rate of generated medical records is as high as 98%, indicating strong acceptance in clinical settings [4] - The average revenue per medical client surged by 116.2% year-on-year to CNY 1.013 million, while revenue from insurance technology services skyrocketed by 1386.8% to CNY 9.963 million [6] Market Position - Cloud Wisdom ranks fourth in the Chinese market for medical AI solutions, with revenue from its large medical model growing by 457.4% in the first half of the year [6] - The rapid inclusion in the Hang Seng Index not only reflects confidence in the AI healthcare sector but also highlights the rarity of its combination of advanced technology and deep market applications [6] - The influx of funds from the Hong Kong Stock Connect is expected to accelerate Cloud Wisdom's expansion in smart healthcare and insurance technology sectors [6]

Core Viewpoint - The company, Yunzhisheng (09678.HK), has submitted an application to the China Securities Regulatory Commission (CSRC) to convert a total of 24,488,277 domestic unlisted shares and 4,570,649 unlisted foreign shares into H-shares for listing on the Hong Kong Stock Exchange [1] Group 1 - The total number of shares to be converted includes 24,488,277 domestic unlisted shares and 4,570,649 unlisted foreign shares [1] - The conversion of these shares into H-shares is subject to approval from relevant regulatory bodies, including the CSRC and the Hong Kong Stock Exchange [1] - As of the date of the announcement, the company has not yet completed the filing with the CSRC regarding this application [1] Group 2 - The company will provide further announcements regarding the progress and details of the application at an appropriate time [1]

智通财经APP讯，云知声(09678)发布公告，公司已于本公告日期向中国证监会提交申请，以将公司 2448.83万股境内非上市股份及457.06万股非上市外资股(统称非上市股份)转为公司H股。在取得所有相 关监管机构(包括但不限于中国证监会及联交所)的备案及╱或批准及符合所有适用法律法规后，该等非 上市股份将被转为H股及合资格在联交所主板上市买卖。 ...

Core Viewpoint - The company Yunzhisheng (09678) has submitted an application to the China Securities Regulatory Commission (CSRC) to convert a total of 24.4883 million domestic unlisted shares and 4.5706 million unlisted foreign shares into H-shares for listing on the Hong Kong Stock Exchange [1] Group 1 - The total number of domestic unlisted shares to be converted is 24.4883 million [1] - The total number of unlisted foreign shares to be converted is 4.5706 million [1] - The conversion is subject to approval from relevant regulatory bodies, including the CSRC and the Hong Kong Stock Exchange [1]

本公告乃由雲知聲智能科技股份有限公司（「本公司」）根據香港聯合交易所有限公司證 券上市規則（「上市規則」）第13.09條及證券及期貨條例第XIVA部作出。 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表 任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責任。 UNISOUND AI TECHNOLOGY CO., LTD. 雲知聲智能科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：9678） 內幕消息 本公司申請股份全流通 本次股份全流通以及轉換及上市尚須履行中國證監會、聯交所及其他境內外監管機構 所要求的其他相關程序。本公司股東及潛在投資者於買賣本公司股份時務請審慎行事。 承董事會命 雲知聲智能科技股份有限公司 茲提述中國證券監督管理委員會（「中國證監會」）於2019年11月14日發佈並於2023年8月 10日修訂的《H股公司境內未上市股份申請「全流通」業務指引》及於2023年2月17日發佈 的《境內企業境外發行證券和上市管理試行辦法》有關香港聯合交易所有限公司（「聯交 所」）上 ...